Effect of Parallel Oxygen Delivery Through a Tracheal Gas Insufflation (TGI) and a T-piece, on Blood Gases and Respiratory Rate, in ICU Tracheostomized Patients

NCT03040297 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2018-01-10

No results posted yet for this study

Summary

The study investigates if there are benefits (better oxygenation, minimized work of breath) from the parallel oxygenation with Tracheal Gas Insufflation and T-piece, in order to provide respiratory support in tracheostomized patients and avoid mechanical ventilation.

Conditions

  • Resp Gas Exchange Disorder Nos

Interventions

DEVICE

Tracheal gas insufflation 6 L/min

Endotracheal flow (6 L/min) of respiratory gases with standard FiO2

DEVICE

Tracheal gas insufflation 11 L/min

Endotracheal flow (11 L/min) of respiratory gases with standard FiO2

DEVICE

Tracheal gas insufflation catheter, without gas flow

Tracheal gas insufflation catheter, without gas flow

Sponsors & Collaborators

  • National and Kapodistrian University of Athens

    collaborator OTHER
  • Attikon Hospital

    lead OTHER

Principal Investigators

  • Konstantinos E Grigoriadis, Pt, MSc · National and Kapodistrian University of Athens

  • Iraklis Tsagaris, MD. PhD · National and Kapodistrian University of Athens

  • Antonia D Koutsoukou, MD, PhD · National and Kapodistrian University of Athens

  • Eirini P Grammatopoulou, PT, PhD · Technological Educational Institution of Athens

  • Anna K Grigoriadou, PT · Lamia University of Applied Sciences

  • Apostolos E Armaganidis · National and Kapodistrian University of Athens

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
86 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-01-31
Completion
2017-05-31

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03040297 on ClinicalTrials.gov